Portland, OR, June 22, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Bleeding disorders Market by Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease and Others), by Treatment Type (Factor Replacement Therapy and Drug Therapy), by Distribution Channel (Hospital pharmacies, Drug Stores & Retail and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032”. According to the report, the global bleeding disorder market is valued at $13.8 billion in 2022 and is estimated to reach $26 billion by 2032, exhibiting a CAGR of 6.6% from 2023 to 2032.
Download Sample Copy - https://www.alliedmarketresearch.com/request-sample/2801
Prime determinants of growth
Rise in prevalence of bleeding disorders such as hemophilia A & B, which further increases the demand of antihemophilic drug and increase in funding to conduct R&D activities for the development of novel therapy to treat bleeding disorders acts as a key driving factor for the growth of the global bleeding disorder market. However, the high cost of hemophilia treatment, and serious adverse effects associated with plasma derived products are expected to hamper the bleeding disorder market growth. On the contrary, surge in healthcare expenditure, and unmet medical demands to get better treatment options for hemophilia in developing countries are expected to create immense opportunities for the expansion of the global market in the future.
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2023–2032 |
| Base Year | 2022 |
| Market Size in 2022 | $13.8 billion |
| Market Size in 2032 | $26 billion |
| CAGR | 6.6% |
| No. of Pages in Report | 458 |
| Segments covered | Disease Type, Treatment Type, Distribution Channel and Region. |
| Drivers | Rise in prevalence of hemophilia |
| Technological advancements in treatment of hemophilia Favorable government initiatives for hemophilia management | |
| Opportunities | Rise in awareness about bleeding disorders in developing countries |
| Restraints | High cost of bleeding disorders treatments |
Covid-19 Scenario
- The global bleeding disorders market was negatively impacted during the pandemic. The pandemic led to delays in routine medical appointments and diagnostic testing, which resulted to delayed diagnoses and treatment of bleeding disorders.
- The bleeding disorders market is expected to recover in the post-pandemic period. Rise in awareness in pharmaceutical companies, and governments regarding supply chain hinderance of pharmaceutical products drives the growth of bleeding disorders market.
Procure Complete Report at 20% Discount (458 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/bleeding-disorders-market
The hemophilia A segment to maintain its leadership status throughout the forecast period
Based on disease type, the hemophilia A segment held the highest market share in 2022, accounting for nearly half of the global bleeding disorder market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to increase in prevalence of hemophilia A and increase in research & development activities for the development of novel therapies to treat hemophilia A. The same segment is estimated to showcase the fastest CAGR of 7.1% from 2023 to 2032.
The factor replacement therapy segment to maintain its leadership status throughout the forecast period
Based on treatment type, the factor replacement therapy segment held the highest market share in 2022, accounting for nearly three-fifths of the global bleeding disorder market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to an increase in the prevalence of severe hemophilic patients and surge in number of research & development activities, and increase in number of clinical trials, for the development of novel factor replacement therapy based drugs. The same segment would cite the highest CAGR of 6.7% during forecast period.
The drug stores and retail pharmacies segment to maintain its lead position during the forecast period
Based on distribution channel, the drug stores and retail pharmacies segment accounted for the largest share in 2022, contributing to more than half of the global bleeding disorder market revenue, owing to surge in aging population and increase in health consciousness. However, the hospital pharmacies segment is expected to portray a fastest growth with a CAGR of 7.0% from 2023 to 2032. This is owing to the fact that hospital pharmacies offer the precise drug according to severity of bleeding disorder in patient. Therefore, patients mostly prefer hospital pharmacy.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/2801
North America to maintain its dominance by 2032
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than half of the global bleeding disorder market revenue, and is likely to dominate the market during the forecast period. This is attributed to surge in cases of bleeding disorder, strong presence of key players, and availability of advanced healthcare system & modern medical technologies. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.0% from 2023 to 2032 , owing to the presence of large hemophilia patient population, rise in demand of drugs of bleeding disorder due to high population base, and increase in public–private investments for unmet medical needs.
Leading Market Players: -
- Bayer AG
- CSL Ltd. (CSL Behring)
- F. Hoffmann-La Roche AG
- Grifols, S.A.
- Medexus Pharma Inc.,
- Novo Nordisk A/S
- Octapharma AG
- Pfizer Inc.
- SANOFI Corporation
- Takeda Pharmaceutical Company Limited
The report provides a detailed analysis of these key players of the global bleeding disorder market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Trending Reports in Healthcare Industry-
Companion Diagnostic Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Infant Incubator Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Influenza Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Alopecia Treatment Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Pneumonia Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Empty Capsules Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
“We have also published few syndicated market studies in the similar area that might be of your interest. Below is the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
